CFN Media Exclusive Executive Interview: Grown Rogue Goes Public
Ryan Allway November 28th, 2018 Exclusive, News, Top News Grown Rogue International Inc. (CSE: GRIN) went public on November 26, 2018, following its reverse takeover of Novicius Corp. on November 16. The company is a premier vertically-integrated, multi-state brand specializing in “seed to experience” products, with an experienced... Read more
Supreme Cannabis Focused on Disciplined Deployment of Capital
Ryan Allway November 21st, 2018 Exclusive, News, Top News The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly... Read more
MedMen Expanding Across the US Legal Cannabis Markets
Ryan Allway November 15th, 2018 Exclusive, News, Top Story The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The... Read more
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries
Ryan Allway November 13th, 2018 Exclusive, News, Top News The cannabis industry is projected to generation hundreds of billions of dollars of revenue over the coming years, driven by the legalization of medical and recreational cannabis across North America. While many investors are focused on cultivation or dispensary... Read more
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top News In late October of this 2018, 48North Cannabis Corp. (TSX-V: NRTH) entered into a binding letter agreement to acquire all issued and outstanding common shares of privately-held Good & Green, a socially-responsible, organic cannabis brand. Combined with... Read more
CFN Media’s Exclusive Interview with Pascal Biosciences
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top Story The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. While many investors are familiar with... Read more
MediPharm Labs Perfecting Cannabis Extracts, Plus Exclusive Executive Interview
Robin Lefferts November 5th, 2018 Exclusive, Feature Stories, News The cannabis market is moving toward oils, extracts, and cannabis-derived products based on oils and extracts. As the cannabis industry comes into the regulatory light of day consumers are consistently showing their preference for oils and associated products over... Read more
Latin America: The Next Cannabis Frontier
Ryan Allway November 2nd, 2018 Exclusive, News, Top News North America has dominated cannabis headlines over the past several years with the legalization of medical and adult-use cannabis across Canada and a growing number of U.S. states. But over the past couple of years, the Latin American cannabis... Read more
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition
Ryan Allway October 26th, 2018 Exclusive, Feature Stories, News Canada’s cannabis industry could experience a dramatic windfall with the legalization of recreational cannabis in October, but many cannabis companies are looking beyond the borders for opportunities. In particular, the most progressive cannabis companies are building up both their... Read more
Who is Focused on the Huge Opportunity in Medical Cannabis?
Robin Lefferts October 18th, 2018 Exclusive, Feature Stories, News With California’s adult-use legalization fresh in investors’ minds, and full legalization happening in Canada, much of the focus has been around the retail potential of cannabis and related products. That is quite a change from even a couple of years... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )